Cargando…

Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology

OBJECTIVES: To evaluate the analysis and reporting of comparative effectiveness research with observational data in rheumatology, informing European Alliance of Associations for Rheumatology points to consider. METHODS: We performed a systematic literature review searching Ovid MEDLINE for original...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauper, Kim, Kedra, Joanna, de Wit, Maarten, Fautrel, Bruno, Frisell, Thomas, Hyrich, Kimme L, Iannone, Florenzo, Machado, Pedro M, Ørnbjerg, Lykke M, Rotar, Ziga, Santos, Maria Jose, Stamm, Tanja A, Stones, Simon R, Strangfeld, Anja, Landewé, Robert BM, Finckh, Axel, Bergstra, Sytske Anne, Courvoisier, Delphine S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601074/ https://www.ncbi.nlm.nih.gov/pubmed/34789534 http://dx.doi.org/10.1136/rmdopen-2021-001818

Ejemplares similares

Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
por: Mongin, Denis, et al.
Publicado: (2022)

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
por: Lauper, Kim, et al.
Publicado: (2022)

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations
por: Kedra, Joanna, et al.
Publicado: (2019)

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
por: Michelsen, Brigitte, et al.
Publicado: (2023)

Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
por: Mongin, Denis, et al.
Publicado: (2019)

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries
por: Lauper, Kim, et al.
Publicado: (2018)

P61 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

Three handy tips and a practical guide to improve your propensity score models
por: Bergstra, Sytske Anne, et al.
Publicado: (2019)

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

Perils of Observational Data Analyses
por: Robinson, Jennifer G.
Publicado: (2019)

IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults
por: Hočevar, Alojzija, et al.
Publicado: (2016)

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
por: Mercer, Louise K, et al.
Publicado: (2017)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

The perils of conducting meta-analyses of observational data
por: Harling, Guy, et al.
Publicado: (2014)

EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis
por: Boonen, Annelies, et al.
Publicado: (2021)

EULAR recommendations for a core data set for pregnancy registries in rheumatology
por: Meissner, Yvette, et al.
Publicado: (2021)

Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis
por: Hum, Ryan M, et al.
Publicado: (2022)

The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data
por: Davies, Rebecca, et al.
Publicado: (2020)

The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register
por: Humphreys, Jennifer H, et al.
Publicado: (2013)

EULAR definition of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2021)

EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future
por: Alunno, Alessia, et al.
Publicado: (2021)

Analyses of ‘change scores’ do not estimate causal effects in observational data
por: Tennant, Peter W G, et al.
Publicado: (2021)

Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project
por: van Beers-Tas, Marian H, et al.
Publicado: (2018)

COVID-19 among patients with giant cell arteritis: a single-centre observational study from Slovenia
por: Kramarič, Jelka, et al.
Publicado: (2022)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups
por: Najm, Aurélie, et al.
Publicado: (2018)

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Observing and analysing natural language : a critical account of sociolinguistic method /
por: Milroy, Lesley

Temporomandibular Disorders and Oral Features in Systemic Lupus Erythematosus Patients: An Observational Study of Symptoms and Signs
por: Crincoli, Vito, et al.
Publicado: (2020)

Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
por: Mahaux, Olivia, et al.
Publicado: (2015)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative
por: van Onna, Marloes, et al.
Publicado: (2021)

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
por: Najm, Aurélie, et al.
Publicado: (2019)

EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology
por: Dejaco, Christian, et al.
Publicado: (2018)

EULAR Kongress-Splitter
por: Bach, Bianca
Publicado: (2021)

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis
por: van Ouwerkerk, Lotte, et al.
Publicado: (2023)

Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups
por: Najm, Aurélie, et al.
Publicado: (2018)

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis
por: Bergstra, Sytske Anne, et al.
Publicado: (2017)

Short-Period Binary Stars: Observations, Analyses, and Results
por: Milone, Eugene F, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_mrn2rkj01dcocsueb4v31nasj8